rs41288015

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001134831.2(AHI1):​c.2624-6A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0206 in 1,605,156 control chromosomes in the GnomAD database, including 443 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 37 hom., cov: 32)
Exomes 𝑓: 0.021 ( 406 hom. )

Consequence

AHI1
NM_001134831.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0002084
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.540

Publications

3 publications found
Variant links:
Genes affected
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
AHI1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 6-135427313-T-C is Benign according to our data. Variant chr6-135427313-T-C is described in ClinVar as [Benign]. Clinvar id is 128325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0158 (2392/151688) while in subpopulation NFE AF = 0.0246 (1663/67582). AF 95% confidence interval is 0.0236. There are 37 homozygotes in GnomAd4. There are 1150 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHI1NM_001134831.2 linkc.2624-6A>G splice_region_variant, intron_variant Intron 19 of 28 ENST00000265602.11 NP_001128303.1 Q8N157-1Q8NER0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHI1ENST00000265602.11 linkc.2624-6A>G splice_region_variant, intron_variant Intron 19 of 28 1 NM_001134831.2 ENSP00000265602.6 Q8N157-1

Frequencies

GnomAD3 genomes
AF:
0.0158
AC:
2393
AN:
151570
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00457
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0116
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00435
Gnomad FIN
AF:
0.0270
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0246
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.0156
AC:
3740
AN:
239992
AF XY:
0.0151
show subpopulations
Gnomad AFR exome
AF:
0.00439
Gnomad AMR exome
AF:
0.00973
Gnomad ASJ exome
AF:
0.0109
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0270
Gnomad NFE exome
AF:
0.0224
Gnomad OTH exome
AF:
0.0189
GnomAD4 exome
AF:
0.0211
AC:
30682
AN:
1453468
Hom.:
406
Cov.:
30
AF XY:
0.0204
AC XY:
14751
AN XY:
722744
show subpopulations
African (AFR)
AF:
0.00346
AC:
115
AN:
33236
American (AMR)
AF:
0.0102
AC:
448
AN:
44128
Ashkenazi Jewish (ASJ)
AF:
0.0100
AC:
260
AN:
25912
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39434
South Asian (SAS)
AF:
0.00556
AC:
474
AN:
85178
European-Finnish (FIN)
AF:
0.0260
AC:
1375
AN:
52938
Middle Eastern (MID)
AF:
0.00320
AC:
18
AN:
5626
European-Non Finnish (NFE)
AF:
0.0243
AC:
26928
AN:
1106988
Other (OTH)
AF:
0.0177
AC:
1064
AN:
60028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1373
2746
4119
5492
6865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1018
2036
3054
4072
5090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0158
AC:
2392
AN:
151688
Hom.:
37
Cov.:
32
AF XY:
0.0155
AC XY:
1150
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.00455
AC:
189
AN:
41502
American (AMR)
AF:
0.0109
AC:
166
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.0116
AC:
40
AN:
3452
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00436
AC:
21
AN:
4822
European-Finnish (FIN)
AF:
0.0270
AC:
286
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0246
AC:
1663
AN:
67582
Other (OTH)
AF:
0.0109
AC:
23
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
115
230
345
460
575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0196
Hom.:
15
Bravo
AF:
0.0137
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Joubert syndrome 3 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Joubert syndrome Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
7.9
DANN
Benign
0.80
PhyloP100
0.54
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00021
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41288015; hg19: chr6-135748451; API